Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.59 USD | -5.45% | -7.98% | -22.06% |
Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
Mar. 26 | Replimune Group, Inc. Announces Management Changes | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- REPL Stock
- Revisions Replimune Group, Inc.